ライフサイエンスコーパス: ARNI

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します

1 atio 0.44, 95% credible interval 0.26-0.66); ARNI+BB+MRA was associated with the greatest reduction i

2 that treatment with ACEI, ARB, BB, MRA, and ARNI and their combinations were better than the treatme

3 96 (84%) were projected to be candidates for ARNI therapy.

4 Eligibility criteria for ARNI therapy, population-based estimates of patients wit

5 Angiotensin receptor neprilysin inhibition (ARNI) therapy provided incremental survival benefit to p

6 s angiotensin receptor neprilysin inhibitor (ARNI), in patients with this disorder.

7 angiotensin receptor-neprilysin inhibitors (ARNI), have not been studied in a head-to-head fashion.

8 nsin receptor blocker neprilysin inhibitors (ARNIs) have been associated with improvements in hospita

9 The combination of ARNI+BB+MRA resulted in the greatest mortality reduction

10 f worsening in the Prospective Comparison of ARNI (angiotensin-receptor-neprilysin inhibitor) with AC

11 (Prospective Comparison of ARNI [Angiotensin Receptor-Neprilysin Inhibitor] with AC

12 In PARADIGM-HF (Prospective Comparison of ARNI [Angiotensin Receptor-Neprilysin Inhibitor] with AC

13 PARADIGM-HF trial (Prospective Comparison of ARNI [Angiotensin Receptor-Neprilysin Inhibitor] With AC

14 action (EF) in the Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality a

15 In the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality a

16 PARADIGM-HF trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality a

17 gated these in the Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality a

18 The PARADIGM-HF (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality a

19 n the PARADIGM-HF (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality a

20 n the PARADIGM-HF (Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality a

21 n the PARADIGM-HF (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality a

22 PARADIGM-HF trial (Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality a

23 The PARADIGM-HF (Prospective Comparison of ARNI With an ACE-Inhibitor to Determine Impact on Global

24 re measured in the Prospective Comparison of ARNI With ARB on Management of Heart Failure With Preser

25 uld be gained from optimal implementation of ARNI therapy at the population level have not been quant

26 Optimal implementation of ARNI therapy was empirically estimated to prevent 28484

27 ly be prevented by optimal implementation of ARNI therapy.

28 deaths prevented or postponed as a result of ARNI were estimated along with multiple-way sensitivity

29 ccount for background therapy suggested that ARNI monotherapy is more efficacious than ACEI or ARB mo

30 substitution of ACE inhibitors or ARBs with ARNIs in appropriate patients.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。